Reproductive health & culture vs GIDEON platform Uso & Estadísticas

This is an app that let users access an online orientation course on "Cultural and Islamic considerations of sexual and reproductive health in EMR".
  • App Store de Apple
  • Gratis
  • Educación

Clasificación de tiendas

- -

GIDEON is ideally suited to save time in Point-of-Care settings while empowering clinicians to consider all possible scenarios. It is a powerful learning tool for Microbiology, Public Health, and Medical students and Residents. Unique features: * Dynamic comparison tables for diseases, drugs, and pathogens * Bayesian analysis-based differential diagnosis (DDx) and pathogen identification tools * First Case Scenario, developed in consultation with the WHO to identify initial cases of known diseases in new settings * Why Not feature, explaining why a given disease did not appear on the list * Interactive historical disease outbreaks and distribution maps, with data going back as far as 1348 AD * A vast epidemiological database covering 230+ geographical areas, updated daily What's inside? 360+ infectious diseases 30,000+ anti-infective drug trade names 75+ vaccines 2,000+ pathogens 235 countries and territories 99,000+ prevalence and seroprevalence surveys 38,000+ graphs 3,200+ images 27,000+ outbreaks 24,000+ country-specific notes 300,000+ references
  • App Store de Apple
  • Gratis
  • Educación

Clasificación de tiendas

- -

Reproductive health & culture frente a GIDEON platform: comparación de la clasificación

Comparar la tendencia de clasificación de Reproductive health & culture en los últimos 28 días con GIDEON platform

Rank

No hay datos disponibles

Comparación de las clasificaciones Reproductive health & culture frente a GIDEON platform por países

Comparar la tendencia de clasificación de Reproductive health & culture en los últimos 28 días con GIDEON platform

No hay datos para mostrar

Compara con cualquier sitio gracias a nuestra prueba gratuita

Empieza ya
Reproductive health & culture VS.
GIDEON platform

enero 11, 2025